year 16, Issue 6 (November - December 2022)                   Iran J Med Microbiol 2022, 16(6): 609-614 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fakhraddin Raheem T, Ahmed Hasan Ali S. Prevalence and Multi-Drug Resistance Patterns of Uropathogenic E.coli isolated from Women Patients in Kirkuk city, Iraq. Iran J Med Microbiol 2022; 16 (6) :609-614
URL: http://ijmm.ir/article-1-1976-en.html
1- Microbiologist, College of dentistry, AL-Kitab University, Kirkuk, Iraq
2- Microbiologist, College of agriculture Alhawija, Kirkuk University, Kirkuk, Iraq , sarahahmed100@uokirkuk.edu.iq
Full-Text [PDF 737 kb]   (610 Downloads)     |   Abstract (HTML)  (2128 Views)
Full-Text:   (592 Views)
Introduction


E.coli is a member of Enterobacteriaceae family and gram-negative bacilli. Some strains of it cause diarrhea, food poisoning and urinary tract infections. Many genera of bacteria can cause urinary tract infections. In fact, uropathogenic E.coli is responsible for 80 - 90% of urinary tract infections globally (1). Urinary tract infections (UTI) are a result of bacterial colonization to the urinary system and occur with high frequency in females of all age groups. E. coli is considered the most significant pathogen isolated from UTIs patients. Moderate or severe dysuria is considered the most common symptom of UTIs. In addition to fever, flank pain, or nausea and vomiting (2).
Urinary tract infections are more significant and common in women because of the short urethra of women which causes more easy traveling of microorganisms into the bladder and the inoculation of microorganisms into the bladder is increased by the sexual activities and delayed post-coital urination with using of the diaphragm as a birth control measures are aid the recurrent UTIs in women (3, 4). The risk of recurrent urinary tract infections increases if the symptoms continue for at least 7 days (3). In addition, the high resistance rate towards the commonly used antibiotics might also play an important role in causing recurrent and complicated UTI (5).
This study determined the prevalence rate of uropathogenic E.coli isolated from Women Patients and studied the multidrug resistance patterns of these isolates in Kirkuk city, Iraq.


 

Materials and Methods

Sample Collection

Collection of 200 Urine samples from women of different ages with symptoms of UTI were achieved over a period from January to May 2022 at women's and children's Hospital in Kirkuk city, Iraq. Then inoculated on Nutrient, MacConkey, and blood agar and incubated at 37о C for 24 hours. The presence of ≥ 105 colonies was revealed as a UTIs (5). Identification was proceeded by following the guidelines of standard biochemical tests.

Antimicrobial Resistance

Antimicrobial resistance was proceeded by the disk diffusion method according to the guidelines of CLSI (6). Antibiotics were used: Augmentin(10μg); trimethoprim- sulfamethoxazole (SXT: 1.25/23.75µg); levofloxacin (LEV:5μg); ceftazidime (CAZ: 30μg); ceftriaxone (CRO:30μg); meropenem (MEM:10μg); azithromycin (Azi:15μg); amikacin(AK:30μg); refampicin(RA:30μg); ciprofloxacin(CIP:5μg); and nitrofurantoin(F:300μg). Their resistance detected Multi Drug Resistant of Uropathogenic E.coli isolates towards three or more antibiotic classes (7, 8).

Data Analysis

Microsoft Excel 2010 was used for the statistical analysis of our results.

 
 

Results

This study reported 132(66%) positive bacterial growth from 200 women patients' urine samples as mentioned below in Figure.1.
 
Figure 1. Prevalence of positive growth among total women urine samples.
Figure 1. Prevalence of positive growth among total women urine samples.
 
Distribution of UTI bacterial isolates from total positive growth was E.coli 47(35.6%), S.aureus 37(28.03%), Staphylococcus spp. 9(6.81), Proteus mirabilis 9(6.81), Klebsiella sp. 9(6.81), Pseudomonas aeruginosa 7(5.3%), Streptococcus spp. 7(5.3%), Acinetobacter baumannii 4(3%) and shigella spp. 3(2.27%). As mentioned below in table 1.
The E.coli isolates rate among women urine samples was 47 (35.6%) isolates, as mentioned below in (Figure 2).
Most of E. coli isolates (n=26; 55.31%) were isolated from women patients in age group 18-38 years old (Figure 3).
 
Table 1. Distribution of UTI bacterial isolates from total positive growth
NO.   Percentage(%) UTI bacterial isolates
E.coli
S.aureus
Staphylococcus spp.
Proteus mirabilis.
Klebsiella spp.
Pseudomonas aeruginosa.
Streptococcus spp.
Acinetobacter baumannii.
Shigella spp.
132 Total
 Figure 2. Prevalence of E.coli in among positive growth women urine samples.
Figure 2. Prevalence of E.coli in among positive growth women urine samples.
 
 
 Figure 3. The E.coli isolates rate according to women patients' age group
Figure 3. The E.coli isolates rate according to women patients' age group
 
E.coli isolates were showed 100% resistance towards Augmentin. In contrast, these isolates showed no resistance to meropenem (0%) and reported various resistance towards various antibiotics as mentioned in (Figure 4).
 
 Figure 4. Resistance pattern of E.coli isolates.
Figure 4. Resistance pattern of E.coli isolates.
 
The MDR patterns of Uropathogenic E.coli isolates were classified into various groups (Types 1-4). Antibiotyping of Type 1 shows resistance towards all seven classes of antibacterials used in current study, while the Type 4 revealed resistance towards 4 classes, as shown below in table2.

 
Table2. Multidrug resistance pattern of the E.coli isolates.

Resistance of antibiotics No. of  E.coli isolates (%) No. of classes Type
AMC,RA,CAZ,CRO,CIP,F,AK,SXT,LEV,AZI. 5(10.63%) 7 1
AMC,RA ,CAZ,CRO,CIP,F, SXT,LEV,AZI 9(19.14%) 6 2
AMC,RA ,CAZ,CRO,F, SXT,LEV. 15(31.91%) 5 3
AMC,RA ,CAZ,CRO,F, SXT. 18(38.29%) 4 4


 

Discussion

UTI is one of the most prevalent infections globally. Although every person is susceptible to UTIs, some persons, such as females, are more effectible to these infections because of their physiological and anatomical features (5, 8).
The prevalence of bacterial positive growth was 132(66%), distributed as the following: E.coli 47(35.6%), S.aureus 37(28.03%), Staphylococcus spp. 9(6.81), Proteus mirabilis 9(6.81), Klebsiella sp. 9(6.81), Pseudomonas aeruginosa 7(5.3%), Streptococcus spp. 7(5.3%), Acinetobacter baumannii 4(3%) and shigella spp. 3(2.27%), these findings were close to Nahab et al. in 2022 and Assafi et al. in 2022  [10,17]. E. coli was the common cause of UTI (35.6%), while other studies revealed such results as 31.8% and 38.1% (9, 10). The variations in the rates among different studies might belong to many points, such as differences in geographical location and the hygienic culture of the studied society (7, 11-13). E. coli isolates were obtained from women in the age group 18-38 years with the highest rate of 55.31% (Figure3); this was agreed with the finding of Nahab et al. in 2022 (10) because of the medical fact of women sexual activity and reproductive activity are increased during these periods; thus causing infection by inoculating the microorganisms into the urinary tract (10, 14-18).
Meropenem showed the highest effect with no resistant E. coli isolates, followed by Amikacin, Ciprofloxacin, Azithromycin, Levofloxacin, Trimethoprim and Nitrofurantoin (10.63%, 19.14%, 19.14%, 31.91%, 38.29% and 38.29%%) respectively as mentioned in (Figure 4), these findings were closed to Al-Guranie and Al-Mayahie in 2020 and Assafi et al in 2022 (19, 20). In contrast, Augmentin revealed no effect towards these isolates with 100% resistance, followed by Ceftazidime, Rifampicin and Ceftriaxone (78.72%, 72.34%and 59.57%) respectively (Figure 4). These results were close to many studies (15, 16).
The range of exposure the antibiotics by the studied population with their hygienic culture is the major reason for the differences in the prevalence rate of antibiotic resistance among various studies (7, 11-13, 21).
 The current study revealed that E.coli isolates were multidrug resistant to four, five, six and seven antibacterial classes: 18(38.29%), 15(31.91%), 9(19.14%), and 5(10.63%) of E. coli isolates, respectively (Table2). Five E.coli  isolates (type1) showed the highest MDR rate (10.63%) against all 7 classes of antimicrobials drugs that were used in this study, while 19.14% (type2), 31.91% (type3) and 38.29% (type4) of the isolates were MDR resistant towards 6, 5 and 4 classes as mentioned in (Table2). These findings were close to the findings of Al-Guranie and Al-Mayahie in 2020 (19).
Several reasons are participated in increasing MDR E.coli strains in this study such as self-prescription of antibiotics which lead to overuse/misuse of these medications; careless usage of antimicrobial drugs is the most critical reason for developing MDR (22-24). To decrease MDR, Al-Hilali (22) and Lee et al. (25) revealed that the selection of antibiotic for each patient should take into consideration: person and population patterns of antibiotic resistance, the severity of the patient disease, and the potential side effects, which associated with using of antimicrobial drugs. Therefore, using an appropriate antimicrobial drug is significant and essential for any program to decrease the appearance of drug-resistant bacteria and spread them in hospitals (26-29).


 

Conclusion

Periodic surveillance of antibiotic resistance is essential to monitor the variations in the antibiotic sensitivity pattern in any population.
The sensitivity of all E. coli isolates towards meropenem calls for attention that the overuse/misuse of this antibiotic will cause selection pressure and increase the rate of resistance. Therefore, education programs and awareness are important and necessary for the accurate diagnosis of diseases, the right selection, and the wise use of available antibacterial drugs. Thus, periodically monitoring of antibiotic susceptibility pattern of UPEC periodically will guide the wise use of antibacterial drugs and help decrease the bacterial vigor of resistance.


 

Acknowledgment

None.
 

 

Funding

None.

 

Conflicts of Interest

The authors declare any conflict of interest.


 

Type of Study: Original Research Article | Subject: Medical Bacteriology
Received: 2022/10/10 | Accepted: 2022/12/2 | ePublished: 2022/12/12

References
1. Ardakani MA, Ranjbar R. Molecular typing of uropathogenic E. coli strains by the ERIC-PCR method. Electron Physician. 2016;8(4):2291-6. [DOI:10.19082/2291] [PMID] [PMCID]
2. Sabri TS, A. Kareem A. Genotyping Diversity of Echerichia coli isolated from UTI in Iraqi Patients. Med Leg Update. 2020;20(1):1421-7.
3. Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender and Age-Dependent Etiology of Community-Acquired Urinary Tract Infections. Sci World J. 2012;2012:349597. [DOI:10.1100/2012/349597] [PMID] [PMCID]
4. Komaroff AL. Urinalysis and urine culture in women with dysuria. Ann Intern Med. 1986;104(2):212-8. [DOI:10.7326/0003-4819-104-2-212] [PMID]
5. Hussein NR, Daniel S, Salim K, Assafi MS. Urinary Tract Infections and Antibiotic Sensitivity Patterns Among Women Referred to Azadi Teaching Hospital, Duhok, Iraq. Avicenna J Clin Microb Infec. 2017;5:27-30. [DOI:10.34172/ajcmi.2018.05]
6. Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility, Twenty-Fourth Information Supplement, CLSI Document M100-S26. CLSI Wayne PA USA; 2016.
7. Ahmed Hasan S, Najati AM, Abass KS. Prevalence and antibiotic resistance of "pseudomonas aeruginosa" isolated from clinical samples in Kirkuk City, Iraq. Eurasia J Biosci. 2020;14(1):1821-5.
8. Ahmed Hasan S, Fakhraddin Raheem T, Mohammed Abdulla H. Phenotypic, Antibiotyping, and Molecular Detection of Klebsiella Pneumoniae Isolates from Clinical Specimens in Kirkuk, Iraq. Arch Razi Inst. 2021;76(4):1061-7.
9. Abdullah IM. Multiple Drugs Resistance Among Urinary Tract Infection Patients In Duhok City -Kurdistan Region -Iraq. Duhok Med J. 2019;13(1):22-31. [DOI:10.31386/dmj.2019.13.1.3]
10. Nahab HM, Akeel Hamed Al-Oebady M, Aqeel Abdul Munem H. Bacteriological Study of Urinary Tract Infections among Pregnant Women in Al Samawa City of Iraq. Arch Razi Inst. 2022;77(1):107-12.
11. Hasan SA, Abass KS. Prevalence of Gram Negative Bacteria Isolated from Patients with Burn Infection and their Antimicrobial Susceptibility Patterns in Kirkuk City, Iraq. Indian J Public Health Res Dev. 2019;10(8):2197. [DOI:10.5958/0976-5506.2019.02184.3]
12. Ahmed Hasan S, Mohammed Bakr M. Bacteriological and Molecular Detection of Klebsiella oxytoca and its Resistance to Antibiotics among Clinical Specimens from Kirkuk, Iraq. Arch Razi Inst. 2022;77(5):1521-5.
13. Ahmed Hasan S, Saleh I, Ali H. Bacteriological and Molecular Detection of Staphylococcus Aureus and its Resistance to Methicillin among Specimens from Kirkuk Community. Ann Rom Soc Cell Biol. 2021;25(7):461-73.
14. Tutuncu L, Ardic N, Mungen E, Ergur AR, Yergok YZ. Urinary tract infection in pregnancy. Prenat J. 2005;13(4):47.
15. Tahir Jarjees Y, Satam Z. In vitro resistance to cephalosporins in women with bacterial urinary tract infections. Iraqi Postgrad Med J. 2012;11(3):321-5.
16. Kareem IJ, Rasheed IY. Antibiotic susceptibilities of gram negative aerobic bacteria isolated from urinary tract infections in community. Iraqi J Med Sci. 2011;9(4):295-300.
17. Johnson JR, Tiu FS, Stamm WE. Direct antimicrobial susceptibility testing for acute urinary tract infections in women. J Clin Microbiol. 1995;33(9):2316-23. [DOI:10.1128/jcm.33.9.2316-2323.1995] [PMID] [PMCID]
18. Biadglegne F, Abera B. Antimicrobial resistance of bacterial isolates from urinary tract infections at FelgeHiwot Referral Hospital Ethiopia. Ethiop J Health Dev. 2009;23(3):236-8. [DOI:10.4314/ejhd.v23i3.53248]
19. Al-Guranie DR, Al-Mayahie SM. Prevalence of E. coli ST131 among Uropathogenic E. coli Isolates from Iraqi Patients in Wasit Province, Iraq. Int J Microbiol. 2020;2020:8840561. [DOI:10.1155/2020/8840561] [PMID] [PMCID]
20. Assafi MS, Ali FF, Polis RF, Sabaly NJ, Qarani SM. An Epidemiological and Multidrug Resistance Study for E. coli Isolated from Urinary Tract Infection (Three Years of Study). Baghdad Sci J. 2022;19(1): 0007-0007. [DOI:10.21123/bsj.2022.19.1.0007]
21. Ahmed Hasan S, Raoof WM, Kamal Rachid S. A Systematic Review: The Current Status of Carbapenem Resistance In Iraq. World Bull Public Health. 2022;13:88-94.
22. Al-Hilali S, Hussein M. Genetic affinities of multiple drug resistant uropathogenic Escherichia coli isolated from patients with urinary tract infection in Najaf. University of Kufa. 2015.
23. Sanjee SA, Karim ME, Akter T, Parvez MA, Hossain M, Jannat B, et al. Prevalence and antibiogram of bacterial uropathogens of urinary tract infections from a tertiary care hospital of Bangladesh. J Sci Res. 2017;9(3):317-28. [DOI:10.3329/jsr.v9i3.31677]
24. Ahmed Hasan S. Pseudomonas aeruginosa and the multifactorial antibiotic resistance. Eurasian Med Res Periodical. 2022;11:85-94.
25. Lee DS, Lee S-J, Choe H-S. Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance. Bio Med Res Int. 2018;2018:7656752. [DOI:10.1155/2018/7656752] [PMID] [PMCID]
26. Abbas FM. Prevalence of Transferable OXA-1 β-Lactamase Associated with Carbapenem-Resistant Klebsiella pneumoniae Isolates in Iraq. J Pure Appl Microbiol. 2021; 15(2):877-82. [DOI:10.22207/JPAM.15.2.43]
27. Al-abedi KJ, Al-Mayahi FA. Molecular Detection of Serine Carbapenemase Genes in Carbapenem-Resistant Isolates of Pseudomonas aeruginosa Recovered from Patients in Al-Diwaniyah Province, Iraq. Iraq J Pure Appl Microbiol. 2019;13(3):1775-82. [DOI:10.22207/JPAM.13.3.53]
28. Hussein ZK, Kadhim HS, Hassan JS. Detection of New Delhi Metallo-Beta-Lactamase-1 (blaNDM-1) in Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Clinical Samples in Wasit Hospitals. Iraqi J Med Sci. 2018;16(3):239-46. [DOI:10.22578/IJMS.16.3.3]
29. Gatya Al-Mayahie SM, Al-Guranie DR, Hussein AA, Bachai ZA. Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province/Iraq. PLoS One. 2022; 17(1):e0262984. [DOI:10.1371/journal.pone.0262984] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc